prednylidene and HIV-Infections

prednylidene has been researched along with HIV-Infections* in 1 studies

Other Studies

1 other study(ies) available for prednylidene and HIV-Infections

ArticleYear
AntiHIV-Pred: web-resource for in silico prediction of anti-HIV/AIDS activity.
    Bioinformatics (Oxford, England), 2020, 02-01, Volume: 36, Issue:3

    Identification of new molecules promising for treatment of HIV-infection and HIV-associated disorders remains an important task in order to provide safer and more effective therapies. Utilization of prior knowledge by application of computer-aided drug discovery approaches reduces time and financial expenses and increases the chances of positive results in anti-HIV R&D. To provide the scientific community with a tool that allows estimating of potential agents for treatment of HIV-infection and its comorbidities, we have created a freely-available web-resource for prediction of relevant biological activities based on the structural formulae of drug-like molecules.. Over 50 000 experimental records for anti-retroviral agents from ChEMBL database were extracted for creating the training sets. After careful examination, about seven thousand molecules inhibiting five HIV-1 proteins were used to develop regression and classification models with the GUSAR software. The average values of R2 = 0.95 and Q2 = 0.72 in validation procedure demonstrated the reasonable accuracy and predictivity of the obtained (Q)SAR models. Prediction of 81 biological activities associated with the treatment of HIV-associated comorbidities with 92% mean accuracy was realized using the PASS program.. Freely available on the web at http://www.way2drug.com/hiv/.. Supplementary data are available at Bioinformatics online.

    Topics: Computer Simulation; HIV; HIV Infections; Prednisolone; Proteins; Software; Structure-Activity Relationship; Viral Proteins

2020